Skip to content
OpenCapital
Get started

Assembly Biosciences ASMB EBIT

EBIT at other companies

ALN
Alnylam PharmaceuticalsALNY
$268.64M+1,386%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$20.9M-42.5%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$168.91M+757%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$132.29M+5.2%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$2.16M+95.6%
Arrowhead Research logo
Arrowhead ResearchARWR
——

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K—
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity0×-0.1×
Current ratio6.6×+4.6×

Where this comes from

Calculated from Assembly Biosciences’s reported figures.

−$11.4Moperating income=-$11.37M

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's EBIT?
Assembly Biosciences (ASMB) reported EBIT of -$11.37M in Q1 2026.
How has Assembly Biosciences's EBIT changed year-over-year?
Assembly Biosciences's EBIT decreased by 14.4% year-over-year, from -$9.94M to -$11.37M.
What is the long-term trend for Assembly Biosciences's EBIT?
Over 3 years (2021 to 2024), Assembly Biosciences's EBIT has grown at a -30.0% compound annual growth rate (CAGR), from -$132.69M to -$45.42M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.